十一月 2025
- Home
- MacroGenics
十一月 2025的MacroGenics市场份额分析
Nasdaq: MGNX), , today announced that the Company's management will. Oct 31, 2023. MacroGenics Announces Date of Third Quarter 2023 Financial Results Conference Call.
MacroGenics(包含公司地区分支机构)
查看更多网站流量和参与度信息- macrogenics.com
MacroGenics收入截至 十一月 2025为 100M - 200M
MacroGenics主要域名产生的收入
3 年中MacroGenics主要域名的收入
MacroGenics主要域名的收入
MacroGenics热门域名的总访问量
了解MacroGenics市场份额和潜在市场覆盖范围。
过去 3 个月的总访问量
子公司明细
MacroGenics热门域名的平均访问时长
分析MacroGenics参与度指标。
过去 3 个月的平均访问时长
子公司明细
MacroGenics热门域名的平均页面浏览量
了解MacroGenics如何保持用户参与度、培养用户兴趣和鼓励采取后续操作。
过去 3 个月的平均页面浏览量
子公司明细
想要获取更深入的流量洞见?
过滤超过 2030 万家在线企业。发现流量激增的新潜在客户,开始或停止使用技术的新潜在客户,或者获得正面报道的新潜在客户。
MacroGenics 的新闻与信号
借助 Similarweb 销售信号提醒,每当在目标受众之中出现新的机会或威胁时,您都会收到所识别出购买信号的每日更新。
新闻MacroGenics, Inc. attended event Goldman Sachs 46th Annual Global Healthcare Conference 2025 on Nov 13th '25.MacroGenics, Inc., a biopharmaceutical company specializing in antibody-based cancer therapies, announced that its President and CEO, Eric Risser, will participate in a fireside chat at the Stifel 2025 Healthcare Conference on November 13, 2025, at 4:00 pm ET in New York City.
十一月 6, 2025阅读更多
新闻MacroGenics, Inc. attends event H.C. Wainwright 27th Annual Global Investment Conference.ROCKVILLE, MD, Sept. 02, 2025 (GLOBE NEWSWIRE) - MacroGenics, Inc. (Nasdaq: MGNX), a biopharmaceutical company focused on developing innovative antibody-based therapeutics for the treatment of cancer, today announced that MacroGenics' President & Chief Executive Officer, Eric Risser, will present at the H.C. Wainwright 27th Annual Global Investment Conference on Monday, September 8, 2025, at 11:30am ET in New York, NY.
九月 2, 2025阅读更多
新闻MacroGenics, Inc. promotes Eric Risser to president and CEO.MacroGenics promotes Eric Risser to president and CEO.
八月 14, 2025阅读更多
查看 MacroGenics 的所有信号
让您的销售团队专注于最有希望的机会。通过分清机会的轻重缓急并在合适的时机介入,您可以优化工作并达成更多交易。